Investment Summary |
|
|---|---|
| Date | 2010-05-03 |
| Target | Ellie Mae |
| Sector | Software |
| Investor(s) | Alta Partners |
| Deal Type | PIPE |
SEARCH BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 48 of 59 |
| Sector: Software M&A | 1 of 1 |
| Type: PIPE M&A Deals | 5 of 5 |
| State: California M&A | 27 of 31 |
| Country: United States M&A | 40 of 50 |
| Year: 2010 M&A | 2 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-29 |
ATS Medical
Minneapolis, Minnesota, United States ATS Medical, Inc., engages in the development, manufacture and marketing of medical devices for the treatment of structural heart diseases. It offers prosthetic heart valves, such as ATS Open Pivot Heart Valve, as well as ATS 3F Aortic Bioprosthesis, a biological replacement aortic heart valve and heart valve repair products. The company also markets and sells surgical cryoablation products for the treatment of cardiac arrhythmias, and it is developing minimally invasive and off-pump aortic valve concepts. |
Sell | $370M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-06-15 |
FoldRx Pharmaceuticals
Cambridge, Massachusetts, United States FoldRx Pharmaceuticals is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis). The Company's lead product, FX-4006, has begun a Phase II/III study in familial amyloid polyneuropathy. FoldRx Pharmaceuticals was founded in 2003 and is based in Cambridge, Massachusetts. |
Buy | - |